Correction: A longitudinal footprint of genetic epilepsies using automated electronic medical record interpretation

[1]  M. Hammer,et al.  The spectrum of intermediate SCN8A‐related epilepsy , 2019, Epilepsia.

[2]  T. Loddenkemper,et al.  Diagnostic yield of genetic tests in epilepsy , 2019, Neurology.

[3]  P. Kind,et al.  GRIN2A-related disorders: genotype and functional consequence predict phenotype , 2018, Brain : a journal of neurology.

[4]  W. Hsu,et al.  Validation of a Natural Language Processing Algorithm for Detecting Infectious Disease Symptoms in Primary Care Electronic Medical Records in Singapore , 2018, JMIR medical informatics.

[5]  Amanda S. Lindy,et al.  Diagnostic outcomes for genetic testing of 70 genes in 8565 patients with epilepsy and neurodevelopmental disorders , 2018, Epilepsia.

[6]  G. Carvill,et al.  Defining the phenotypic spectrum of SLC6A1 mutations , 2018, Epilepsia.

[7]  Sahar Mansour,et al.  PURA syndrome: clinical delineation and genotype-phenotype study in 32 individuals with review of published literature , 2017, Journal of Medical Genetics.

[8]  R. Sagar,et al.  Surgery for Drug‐Resistant Epilepsy in Children , 2017, The New England journal of medicine.

[9]  M. Daly,et al.  De novo variants in neurodevelopmental disorders with epilepsy , 2018, Nature Genetics.

[10]  Edouard Hirsch,et al.  ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology , 2017, Epilepsia.

[11]  Deciphering Developmental Disorders Study,et al.  Prevalence and architecture of de novo mutations in developmental disorders , 2017, Nature.

[12]  Marylyn D. Ritchie,et al.  Distribution and clinical impact of functional variants in 50,726 whole-exome sequences from the DiscovEHR study , 2016, Science.

[13]  Jorie M. Butler,et al.  Determining Multiple Sclerosis Phenotype from Electronic Medical Records , 2016, Journal of managed care & specialty pharmacy.

[14]  Paul A. Harris,et al.  PheKB: a catalog and workflow for creating electronic phenotype algorithms for transportability , 2016, J. Am. Medical Informatics Assoc..

[15]  J. Hurst,et al.  Improving diagnosis and broadening the phenotypes in early-onset seizure and severe developmental delay disorders through gene panel analysis , 2016, Journal of Medical Genetics.

[16]  P. Striano,et al.  STXBP1 encephalopathy , 2016, Neurology.

[17]  I. Helbig,et al.  Diagnostic exome sequencing provides a molecular diagnosis for a significant proportion of patients with epilepsy , 2016, Genetics in Medicine.

[18]  Peter N. Robinson,et al.  The Human Phenotype Ontology: Semantic Unification of Common and Rare Disease , 2015, American journal of human genetics.

[19]  Bale,et al.  Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.

[20]  Boris Yamrom,et al.  The contribution of de novo coding mutations to autism spectrum disorder , 2014, Nature.

[21]  Christopher S. Poultney,et al.  Synaptic, transcriptional, and chromatin genes disrupted in autism , 2014, Nature.

[22]  Epilepsy Phenome,et al.  De novo mutations in synaptic transmission genes including DNM1 cause epileptic encephalopathies. , 2014, American journal of human genetics.

[23]  Gerard Tromp,et al.  Design patterns for the development of electronic health record-driven phenotype extraction algorithms , 2014, J. Biomed. Informatics.

[24]  Michael R. Johnson,et al.  De novo mutations in the classic epileptic encephalopathies , 2013, Nature.

[25]  Melissa A. Basford,et al.  The Electronic Medical Records and Genomics (eMERGE) Network: past, present, and future , 2013, Genetics in Medicine.

[26]  W. Barbaresi,et al.  Mortality, ADHD, and Psychosocial Adversity in Adults With Childhood ADHD: A Prospective Study , 2013, Pediatrics.

[27]  A. Berg,et al.  Age at onset of epilepsy, pharmacoresistance, and cognitive outcomes , 2012, Neurology.

[28]  E. Wirrell,et al.  Predictors and course of medically intractable epilepsy in young children presenting before 36 months of age: A retrospective, population‐based study , 2012, Epilepsia.

[29]  M. Sperling,et al.  Age of onset in idiopathic (genetic) generalized epilepsies: Clinical and EEG findings in various age groups , 2012, Seizure.

[30]  Sunghwan Sohn,et al.  Mayo clinical Text Analysis and Knowledge Extraction System (cTAKES): architecture, component evaluation and applications , 2010, J. Am. Medical Informatics Assoc..

[31]  Marcel H. Schulz,et al.  Clinical diagnostics in human genetics with semantic similarity searches in ontologies. , 2009, American journal of human genetics.

[32]  P. Robinson,et al.  The Human Phenotype Ontology: a tool for annotating and analyzing human hereditary disease. , 2008, American journal of human genetics.

[33]  I. Scheffer,et al.  The spectrum of SCN1A-related infantile epileptic encephalopathies. , 2007, Brain : a journal of neurology.

[34]  Renzo Guerrini,et al.  Epilepsy in children , 2002, The Lancet.

[35]  Anthony L. Johnson,et al.  The United Kingdom Infantile Spasms Study comparing vigabatrin with prednisolone or tetracosactide at 14 days: a multicentre, randomised controlled trial , 2004, The Lancet.

[36]  A. Crescenzi,et al.  Congenital hypotonia with favorable outcome. , 2002, Pediatric neurology.

[37]  A. Tenenbaum,et al.  Developmental correlates of school‐age children with a history of benign congenital hypotonia , 1998, Developmental medicine and child neurology.

[38]  W. Hauser,et al.  A prospective study of recurrent febrile seizures. , 1992, The New England journal of medicine.